Recent Staff Awards, HIV Drug Resistance Program, National Cancer Institute
... Skip navigation links
Link to Home Page of HIV Drug Resistance Program Website
Link to Mission, HIV Drug Resistance Program, National Cancer Institute
Symposium on Antiviral Drug Resistance, External Link
Link to News & Events, HIV Drug Resistance Program, National Cancer Institute
Link to Research Team, HIV Drug Resistance Program, National Cancer Institute
Link to Clinical Trials, HIV Drug Resistance Program, National Cancer Institute
Link to Recruitment, HIV Drug Resistance Program, National Cancer Institute
Link to Resources, HIV Drug Resistance Program, National Cancer Institute
Link to Related Sites, HIV Drug Resistance Program, National Cancer Institute
Link to Staff Directory, HIV Drug Resistance Program, National Cancer Institute

National Cancer Institute, External Link
Link to Frederick National Laboratory for Cancer Research - external website
...

Human Frontier Science Program Grant

    In 2012, Alan Rein was awarded a three-year Program Grant from the Human Frontier Science Program (HFSP) to support his international collaboration with Bogdan Dragnea, Dmitri Svergun, and Paul Van der Schoot on "Physical Principles in the Self-Assembly of Immature HIV-1 Particles."  These highly competitive grants are awarded by HFSP to support innovative projects involving extensive collaboration among teams of independent scientists working in different countries and in different disciplines.

Travel Awards, HIV Drug Resistance Program Think Tank Meeting

    Hyun Yu (KewalRamani lab) received a travel award for one of the two most meritorious postdoctoral presentations at the 2012 Think Tank Meeting.  Recipients of travel awards at previous Think Tank Meetings include Kayoko Waki (Freed lab) in 2011 and Muthukumar Balasubramaniam (Freed lab) and Michal Legiewicz (Le Grice lab) in 2010.  These $1000 stipends were provided by the Center of Excellence in HIV/AIDS & Cancer Virology, Center for Cancer Research, NCI.

2012 NIH Postbaccalaureate Poster Day Award

    The poster presentation by Tiffany Tanzosh scored in the top 20% of all presentations at the 2012 NIH Postbaccalaureate Poster Day.  Moreover, she was ranked among the top 15 presenters in this highly competitive event, and was one of only two NCI postbaccalaureate fellows among the top 15 presenters.

Scholarship Awards, Keystone Symposia on HIV

    KyeongEun Lee was awarded a travel scholarship and her abstract was selected for oral presentation at the 2012 Keystone Symposia on Frontiers in HIV Pathogenesis, Therapy and Eradication; Dr. Lee was also awarded a travel scholarship to present her research findings at the 2006 Keystone Symposia on HIV Pathogenesis.

    Kayoki Waki was awarded a travel scholarship and her abstract was selected for oral presentation at the 2012 Keystone Symposia on Frontiers in HIV Pathogenesis, Therapy and Eradication.

    Nancy P.Y. Chung was awarded a travel scholarship to present her research findings at the 2009 Keystone Symposia on HIV Immunobiology: From Infection to Immune Control.

    Taichiro Takemura, Rebecca Russell, and Michael Moore were awarded travel scholarships to present their research findings at the 2008 Keystone Symposia on HIV Pathogenesis.

Avon Foundation for Women Research Grant

    Alan Rein received a two-year Breast Cancer Research Program grant in 2011 from the Avon Foundation for Women to support a collaborative project on "Testing for MMTV and Related Retroviruses in Breast Cancer" with Edward Gabrielson, M.D., at Johns Hopkins Medical Institution.

2011 Norman P. Salzman Memorial Award in Virology

    Tobias Paprotka won the 2011 Norman P. Salzman Memorial Award in Virology for his work on XMRV.  This annual NIH-wide award is given to only one postdoctoral fellow per year to recognize outstanding research in the field of virology under the mentorship of an NIH, Center for Biologics Evaluation and Research, or SAIC scientist.  Postdoctoral fellows from all NIH campuses, including Bethesda and Frederick, can apply for the award.  Dr. Paprotka will present his research at the Thirteenth Annual Norman P. Salzman Memorial Symposium in Virology on November 10, 2011 and will receive a plaque and a cash award for his achievement.  As Dr. Paprotka's mentor, Vinay K. Pathak (Head of the Viral Mutation Section, HIV Drug Resistance Program, National Cancer Institute) will also receive a plaque at the Symposium.

NIH Fellows Awards for Research Excellence

    The NIH Fellows Award for Research Excellence (FARE) acknowledges outstanding scientific research performed by intramural postdoctoral fellows.  The award is sponsored by the NIH Fellows Committee, the Scientific Directors, the NIH Office of Research on Women's Health, and the NIH Office of Intramural Training and Education, and is funded by the Scientific Directors and the Office of Research on Women's Health.  Awards are based on scientific merit, originality, experimental design, and overall quality/presentation of the abstracts.

    The following Fellows in the HIV Drug Resistance Program (DRP) won 2012 FARE stipends of $1000 for travel to attend and present their work at a scientific meeting in the U.S.:

            Kari Dilley
            Lillian Kuo
            Angelica Martins
            Tobias Paprotka
            Narasimhan Jayanth Venkatachari
            Kayoko Waki

    The following DRP Fellows were FARE awardees in 2006-2011:

            Helene Mens (2011)
            Muthukumar Balasubramaniam (2010)
            Wei Bu (2010)
            Nancy P.Y. Chung (2010, 2008)
            Benjamin Luttge (2010)
            Alok Mulky (2010)
            Jessica Smith (2010)
            Catherine Adamson (2009)
            Michael Moore (2009)
            Rebecca Russell (2009)
            Yi Wang (2009)
            Michaela Wendeler (2009)
            Krista Delviks-Frankenberry (2008)
            Mario P.-S. Chin (2007, 2006)
            Chandravanu Dash (2007)
            Yeshitila Friew (2007)
            Karine Gousset (2007)
            Patricia Henry (2007)
            Kazushi Motomura (2007)
            Galina Nikolenko (2007)
            Olga Nikolaitchik (2006)

Photo of Drs. Henry, Nikolenko, Rudick, Gottesman & Friew at 2007 FARE ceremony

    Shown from left to right: Patricia Henry, Galina Nikolenko, Joyce Rudick (Director of Programs and Management, NIH Office of Research on Women's Health), Michael Gottesman (NIH Deputy Director for Intramural Research), and Yeshitila Friew.

Poster Awards, NCI-Frederick Spring Research Festival

    Tobias Paprotka and Nishani Kuruppu won poster awards for their presentations at the 2011 NCI-Frederick Spring Research Festival.

    Other DRP fellows and student trainees who have won poster awards in previous years for their presentations at the NCI-Frederick Spring Research Festival include:

            Michal Legiewicz (2008)
            Krista Delviks-Frankenberry (2007)
            Bilguujin Dorjsuren (2007)
            Leslie Gee (2007)
            Michael Moore (2007)
            Samuel Rulli, Jr. (2007)
            Rebecca Russell (2007)
            Michaela Wendeler (2007)
            Patricia Henry (2006)
            Olga Nikolaitchik (2006)
            Galina Nikolenko (2006)
            Hongzhan Xu (2006)

2011 Intramural AIDS Research Fellowships

    In 2011, the following Visiting Fellows in the HIV Drug Resistance Program received Intramural AIDS Research Fellowship (IARF) awards from the Office of AIDS Research, Office of Intramural Research, and Office of Intramural Research & Training in the National Institutes of Health to support their proposed research projects:

    Lillian Kuo (Freed lab):  "Characterizing the Role of HIV-1 p6-Alix Binding in HIV-1 Cell-to-Cell Infectivity"

    Humeyra Taskent (Le Grice lab):  "Incorporating Unnatural Photoactive Amino Acids into Viral Capsids to Look for Host Proteins with Which They Interact"

    Philip Tedbury (Freed lab):  "HIV-1 Gag in Assembly and Release: Interactions with gp41 and Cellular Host Factors"

    Narasimhan (Jay) Venkatachari (Pathak lab):  "Identification of Small Molecule Inhibitors of Vif-A3G and Vif-A3F Interactions as Novel Antiviral Agents for the Treatment of HIV-1 Infection"

    IARF awards include full stipend support to successful candidates who demonstrate outstanding scientific potential through both an imaginative and thoughtful research plan and a well thought out career development plan.

2010 NCI Mentor of Merit Award

    Eric Freed was selected as an NCI Mentor of Merit in 2010 for excellence in mentoring and guiding the careers of trainees in cancer research.  Dr. Freed was nominated by present and past trainees who view his mentorship as outstanding.  NCI Director Harold Varmus presented the Mentor of Merit citation to him at the NCI Director's Awards ceremony in November 2010.

    Photo of NCI Director Harold Varmus with Eric Freed and other 2010 Mentor of Merit awardees

2010 Multi-Investigator Award Sponsored by Center for Cancer Research (CCR) and Office of AIDS Research (OAR)

    In 2010, Eric Freed and Vineet KewalRamani of the HIV Drug Resistance Program, NCI-Frederick, and Sriram Subramaniam of the Laboratory of Cell Biology, NCI-Bethesda, successfully competed for a $150,000 CCR/OAR-sponsored multi-investigator award with their research proposal "Catching HIV in the act: Structural studies of HIV transport from antigen-presenting cells into the T-cell nucleus."  In total, four CCR/OAR-sponsored awards were made to 11 investigators within and between the Frederick and Bethesda campuses of the National Cancer Institute.

NCI Director's Intramural Innovation Awards

    Photo of NCI Director Harold Varmus presenting award in 2011 to Sabrina LusvarghiIn 2011, Sabrina Lusvarghi (Le Grice lab) received a $10,000 NCI Director's Intramural Innovation Award for her application entitled "Incorporation of Crosslinkable Unnatural Amino Acids for Identifying Binding Partners for XMRV Proteins."  Site-specific incorporation of unnatural amino acids into proteins is a growing area of chemical biology and biochemistry, and the availability of unnatural amino acids with novel biophysical properties is constantly widening the scope of these strategies.  The goal of Dr. Lusvarghi’s proposal involves incorporating photo-crosslinkable unnatural amino acids into viable viruses, an approach that is currently unprecedented.  The novelty of this strategy is that the photo-crosslinkable viruses can be used to study protein-protein interactions in their most-biologically relevant context.  Moreover, previously unknown binding partners identified using this approach could serve as targets for novel antiviral therapies.  Finally, success in this initial investigation will likely spawn parallel studies to identify and characterize binding partners of other XMRV proteins or proteins in related retroviruses of public health significance.
     

    Photo of NCI Director John Niederhuber presenting 2010 award to Legiewicz In 2010, Michal Legiewicz (Le Grice lab) received a $10,000 NCI Director's Intramural Innovation Award for his research proposal entitled "Structural Responses in Tumor Suppressor Messenger RNAs Induced by micro-RNA miR-21 in Breast Cancer."  Dr. Legiewicz initiated this project to investigate how the structure of messenger RNA responds to downregulation by microRNA.  While down- regulation by miR-21 and its binding to target mRNAs have
    been tested in functional and binding assays, the structural response of target mRNAs is unknown.  Dr. Legiewicz's study employs a novel high-throughput RNA-probing technology to monitor structural rearrangements within 3'- and 5'-UTRs in response to miRNA modulation.  He is investigating whether the binding of miR-21 invokes translational inhibition by rearranging a local subdomain or by altering the architecture of long-range interactions within its target mRNAs (which range in size from ~2000-4000 nucleotides).  In order to explore the hypothesis that miR-21 triggers a common structural response in target mRNA causing translational inhibition, Dr. Legiewicz selected three mRNAs for his study.  Each is a direct target of miR-21 and is downregulated in breast cancer.  The results of his study will reveal a novel mechanistic basis for miRNA-directed regulation of gene expression and new molecular targets critical in designing more potent therapies against breast cancer and against cancer in general.  This award is the second that Dr. Legiewicz has received through the NCI Director's Intramural Innovation Award Program (see the text below for a description of his first award).
     

    Photo of NCI Director John Niederhuber presenting award in 2009 to Jason RauschIn 2009, Jason Rausch (Le Grice lab) received a $10,000 NCI Director's Intramural Innovation Award for his application entitled "Incorporating Unnatural Amino Acids into the Pol V Mutasome for Photocrosslinking and Single-Molecule FRET."  Dr. Rausch's innovation entails the expression, purification, and utilization of proteins containing unnatural amino acids to explore structural and mechanistic aspects of DNA repair in unprecedented ways and using state-of-the-art technologies.  These technologies can be applied to a wide variety of experimental systems, including those used for drug screening, in which the presence of numerous or catalytically critical cysteines otherwise prohibits conventional protein labeling.  This award is the second that Dr. Rausch has received through the NCI Director's Intramural Innovation Award Program (see the text below for a description of his first award).
     

    Photo of NCI Director John Niederhuber presenting award to Legiewicz and SanthanamMichal Legiewicz (Le Grice lab) and Arti Santhanam (Colburn lab) were awarded $10,000 from the NCI Director's Intramural Innovation Award Program in 2008 for their proposal "Structural Determinants Within the 5'-UTR of Cancer-Relevant mRNAs Regulated at the Level of Translation."  The NCI Director's Intramural Innovation Award Program is designed to support the development of highly innovative approaches and technology aimed at significant cancer-related problems.  Deregulation of protein synthesis is an early event in cancer progression.  In recent years, considerable effort has been focused on translation as a molecular target for both cancer prevention and therapy.  The novel tumor suppressor PDCD4 functions by inhibiting the RNA helicase activity of the eukaryotic initiation factor eIF4A and hence the efficient translation of specific oncoproteins.  Applying the innovative RNA mapping technology SHAPE to determine structural signatures within the 5'-UTR of various mRNAs will explain why only select mRNAs are targets of PDCD4.  In high throughput, SHAPE will allow examination of multiple RNAs simultaneously or the same RNA under various conditions.  This unique feature makes it possible to monitor minor RNA structural response to the presence/activity of protein factors at different concentrations and test the significance of other co-factors that are important for RNA structure (e.g., divalent cations) or for protein enzymatic function (e.g., ATP).  No other technology offers this unusual combination of sensitivity, flexibility for applied conditions, and high throughput.  High-throughput identification of structural signatures defining oncogenic mRNAs will have tremendous potential in the discovery and design of novel, powerful anticancer drugs.
     

    Photo of NCI Director John Niederhuber presenting award to Jason Rausch

    In 2006-2007, Jason Rausch (Le Grice lab) and Edward C.-K. Wu (Hughes lab) were each awarded $10,000 from the NCI Director's Intramural Innovation Award Program.  Dr. Rausch's innovation, "Evolving Sequence-Specific Integrases and Methyltransferases by In Vitro Compartmentalization and Selection," uses a novel methodology to simultaneously screen millions of enzyme variants, with selection based both on targeted binding/activity and the absence of nonspecific binding activity.  Directed evolution has never been applied in this manner to either of these enzymes, and some of the proposed methods for linking phenotype with genotype are unprecedented.  Dr. Wu's innovation, "Recombinant Human Telomerase Reverse Transcriptase," makes it possible to express and purify enzymatically active recombinant human telomerase.  This advance will allow a much better understanding of the structure and function of human telomerase and has the potential to be used to develop novel anticancer therapies.

2009 and 2007 NCI Mentor of Merit Awards

    In 2009 and 2007, Stuart Le Grice was nominated for the NCI Outstanding Mentor Award and was selected as a Mentor of Merit.  Dr. Le Grice received one of the highest rankings in a competitive review in which nominees were "judged on their records as mentors; their accessibility to trainees; their ability to communicate and provide instruction and constructive feedback; their capacity to provide an environment conducive to science and learning; their propensity to give credit to trainees and promote visibility of their work; and their attention to the career development needs of those they mentor."  NCI Director John Niederhuber presented Dr. Le Grice with the Mentor of Merit citation at the NCI Director's Awards ceremony in October 2009.

2009 NCI-Frederick Student Science Jeopardy Tournament

    Brittany Ashe and David Kaiser-Jones won the 3rd Annual NCI-Frederick Scientific Library Student Science Jeopardy Tournament in 2009, competing against 11 other 2-student teams in the traditional Jeopardy "answer and question" format.  Brittany and David are students working in Stuart Le Grice's group with mentors Jason Rausch and Michal Legiewicz, respectively.

Photo of Jeopardy contest winners Brittany Ashe & David Kaiser-Jones & mentors Jason Rausch & Michal Legiewicz

    Shown from left to right: Jason Rausch, Brittany Ashe,
    Michal Legiewicz, and David Kaiser-Jones


2009 NIH Merit Award

    Stuart Le Grice (HIV Drug Resistance Program, NCI) was nominated and selected to receive a 2009 NIH Merit Award with Robert Yarchoan (HIV and AIDS Malignancy Branch, NCI).  Robert Wiltrout, Director of the Center for Cancer Research, NCI, nominated Drs. Le Grice and Yarchoan for this Group Award, titled HIV/AIDS and HIV Malignancy Leadership Group, for leadership in promoting and supporting research in HIV/AIDS and HIV-associated malignancies in the NCI.

Young Investigator Award, 2008 International Feline Retrovirus Research Symposium

    Benjamin Luttge was awarded the Young Investigator Award for his oral presentation at the 2008 International Feline Retrovirus Research Symposium in Vienna, Austria.

Award for Excellence in Graduate Research, Catholic University of America

    Mary Kearney was awarded the Benedict T. DeCicco Award for Excellence in Graduate Research in 2008 by the Biology Faculty of the Catholic University of America.

Travel Award, 2008 Spring Research Festival Symposium

    Benjamin Luttge won a travel award for the best oral presentation at the 2008
    NCI-Frederick Spring Research Festival Symposium on "Virology: from Genetic Vehicles to Human Pathogens."

Howard Temin Pathway to Independence Award (K99/R00)

    Photo of Chandravanu Dash, Research Fellow in HIV Drug Resistance Program In 2007, Chandravanu (CV) Dash successfully competed for a Howard Temin Pathway to Independence (PI) Award (K99/R00) from the National Institute on Drug Abuse for his proposal "Role of Nucleic Acid Structure in HIV-1 Replication."  The award provides up to five years of support consisting of two phases.  The initial phase will provide one to two years of mentored support (up to $90,000) for highly promising postdoctoral research scientists.  This phase will be followed by up to three years of independent support (up to $249,000) contingent on securing an independent research position.  The primary goal of the PI Award Program is to increase and maintain a strong cohort of new and talented NIH-supported independent investigators.

    The long-term goal of Dr. Dash's PI award is to elucidate the mechanism of interactions between essential viral and cellular enzymes with their nucleic acid substrates during HIV replication.  New and important biochemical data obtained from this proposal are expected to facilitate our understanding of the mechanism of HIV-1 replication, which is essential to designing better and effective drugs against HIV.  Dr. Dash is mentored by Dr. Stuart Le Grice and co-mentored by Dr. Vineet KewalRamani of the HIV Drug Resistance Program at NCI-Frederick.

Postdoctoral Fellowship, Japan Society for the Promotion of Science

    Taichiro Takemura was awarded a Postdoctoral Fellowship from 2007 to 2009 by the Japan Society for the Promotion of Science. The fellowship program sponsored by this society supports meritorious biomedical research projects undertaken in NIH laboratories by Japanese postdoctoral researchers. Fellowships are awarded after a competitive review of research proposals.

Scholarship Award, International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention

    Mario Chin was awarded a scholarship to present his findings at the 2007 IAS Conference on HIV Pathogenesis, Treatment and Prevention in Sydney, Australia.

Travel Scholarship, International HIV Drug Resistance Workshop

    Mary Kearney was awarded a travel scholarship in 2007 to present her research findings at the International HIV Drug Resistance Workshop.

Scholarship Awards, 2007 American Society for Virology Meeting

    Nancy Chung and Alok Mulky were awarded travel scholarships and their abstracts were selected for oral presentation at the 2007 American Society for Virology Meeting.

Young Investigator Awards, Conference on Retroviruses and Opportunistic Infections

    Zandrea Ambrose won Young Investigator Awards in 2006 and 2007 and Catherine Adamson won a Young Investigator Award in 2007 to present their research findings at the Conference on Retroviruses and Opportunistic Infections.

Travel Fellowships Awarded by HIV & Cancer Virology Faculty, NCI

    In 2006, Jean L. Mbisa and Catherine Adamson won two of the three available travel fellowships awarded by the HIV & Cancer Virology Faculty, Center for Cancer Research, National Cancer Institute.


Last modified: 2 May 2012

...



HIV DRP Home
Mission | HIV DRP Symposium | News & Events | Research Team | Clinical Trials | Recruitment | Resources
Related Sites | Staff Directory | NCI Home | Frederick National Lab | Site Map | Disclaimers | Contact Us

Accessibility | Viewing Files

National Cancer Institute     Health and Human Services National Institutes of Health USA Gov - Official Web Portal